[1] |
FU Shengnan, YANG Yun, WANG Cong, LUO Qingli, YU Li.
Preparation and preliminary application of the polyclonal antibody against Toxoplasma gondii dense granule protein 24
[J]. Chinese Journal of Schistosomiasis Control, 2024, 36(3): 279-285.
|
[2] |
ZHOU Guoqing, BAI Shaoyuan, LI Yuyuan, ZHU Guoding, HUANG Siyang.
Preliminary observation on the development and dynamic changes of chronic toxoplasmosis in mice
[J]. Chinese Journal of Schistosomiasis Control, 2024, 36(3): 304-309.
|
[3] |
ZHOU Fangbin, ZHANG Yilong, ZHANG Dongmei.
Latest advances in the development of tuberculosis vaccines in global clinical trials: a review
[J]. Chinese Journal of Schistosomiasis Control, 2024, 36(2): 201-206,218.
|
[4] |
GAN Donghui, FAN Jinqing, ZENG Jinfang, LIN Jun, CHEN Xiaojun.
Seroprevalence of the specific antibody against Toxoplasma gondii among patients with hematological diseases
[J]. Chinese Journal of Schistosomiasis Control, 2024, 36(1): 83-86.
|
[5] |
YANG Zhenke, WANG Jinghui, QI Yiming, TIAN Xiaowei, MEI Xuefang, ZHANG Zhenchao, WANG Shuai.
Bioinformatics analysis of the RNA binding protein DDX39 of Toxoplasma gondii
[J]. Chinese Journal of Schistosomiasis Control, 2023, 35(4): 358-365,373.
|
[6] |
BI Xianglian, FU Xiaoyin, XUE Sa, HAN Xue, ZENG Yulu, SUN Jiayue, LIU Dengyu.
Expression of CD47 and its ligands in pregnant mice infected with Toxoplasma gondii during pregnancy
[J]. Chinese Journal of Schistosomiasis Control, 2023, 35(1): 51-.
|
[7] |
WANG Chong, CAI Yi⁃hong.
Effect of Toxoplasma gondii Chinese 1 genotype infections on brain iron metabolism in mice
[J]. Chinese Journal of Schistosomiasis Control, 2022, 34(4): 361-.
|
[8] |
ZHENG Jia, ZHANG Dong⁃jun, ZHAO Shang⁃qi, LI Yan⁃min, ZHOU Yan⁃xia, ZHOU Wen⁃tao, ZHOU Xiao⁃tao.
Preparation and characterization of a recombinant poly⁃epitopic vaccine EgG1Y162⁃2 (4) against cystic echinococcosis based on the linker GSGGSG
[J]. Chinese Journal of Schistosomiasis Control, 2022, 34(4): 378-.
|
[9] |
ZHANG Rong, SHAO Tian⁃ye, SHAO Chen⁃lu, QIU Jing⁃fan, WANG Yong.
Effects of Toxoplasma gondii infection on mouse and human uterine natural killer cells
[J]. Chinese Journal of Schistosomiasis Control, 2022, 34(2): 149-.
|
[10] |
GAO Qi.
Field evaluation and future applications of the world’s first malaria vaccine
[J]. Chinese Journal of Schistosomiasis Control, 2021, 33(6): 551-.
|
[11] |
FENG Gao⁃qian.
Potential challenges for large⁃scale uses of RTS, S/AS01 vaccine in malaria⁃endemic areas
[J]. Chinese Journal of Schistosomiasis Control, 2021, 33(6): 553-.
|
[12] |
XIAO Bo, HUANG Zheng⁃hui, JIANG Lu⁃bin.
Prospects and reflections on the research and development of next⁃generation malaria vaccines
[J]. Chinese Journal of Schistosomiasis Control, 2021, 33(6): 555-.
|
[13] |
XU Wen⁃yue.
Development and application of the world’s first malaria subunit vaccine RTS, S/AS01
[J]. Chinese Journal of Schistosomiasis Control, 2021, 33(6): 557-.
|
[14] |
ZHANG Yi⁃long, PAN Wei⁃qing.
he world’s first malaria vaccine: Hope and challenge
[J]. Chinese Journal of Schistosomiasis Control, 2021, 33(6): 560-.
|
[15] |
ZENG Yu⁃lu, XUE Sa, BI Xiang⁃lian, YAN Ling⁃xin, YANG Jun, ZHANG Da⁃yi, GOU Yong⁃song, FU Xiao⁃yin, LIU Deng⁃yu.
Expression of hypoxia⁃inducible factor⁃1 in mice infected with Toxoplasma gondii during pregnancy
[J]. Chinese Journal of Schistosomiasis Control, 2021, 33(6): 615-.
|